TRV Travelers Companies Inc.

Travelers Has Helped Injured Employees Cut Opioid Use by 30 Percent Since 2015

The Travelers Companies, Inc., (NYSE: TRV) reported today a 30 percent reduction in the use of opioids among the more than 500,000 injured U.S. employees it has helped since 2015. This has been achieved primarily through the use of the company’s Early Severity Predictor model. The model identifies the likelihood that someone will develop chronic pain – a leading cause of opioid dependency.

Travelers shares the Early Severity Predictor results with the injured employee’s physician allowing them to identify effective treatment alternatives, like physical therapy, and in some cases surgery is avoided to help ensure a safe recovery without the prolonged use of opioids. Since January 2016, surgeries for the company’s workers compensation cases have fallen by 25 percent, and those who received alternative treatment methods recovered and returned to work 10 percent faster than those who did not.

“Surgical procedures used to correct common workplace injuries are oftentimes followed by an opioid prescription for pain,” said Dr. Adam Seidner, Global Medical Director at Travelers, who is also an addiction specialist. “Physical therapy and other treatments limit the employee’s exposure to opioids and often produce better long-term medical outcomes.”

Travelers, the nation’s largest workers compensation carrier, has helped employers reduce medical expenses on identified claims by up to 50 percent since it implemented the Early Severity Predictor model in the beginning of 2015. The company typically handles approximately 250,000 workers compensation claims each year.

Travelers’ in-house pharmacy management program has also contributed to these results. The company’s claim professionals use detailed information gained from training with on-staff pharmacists to assess the merits of requests for pharmaceutical payments and identify the potential for overusing opioids and dangerous drug interactions.

For more information about workers compensation products and services from Travelers, visit www.travelers.com.

About Travelers

The Travelers Companies, Inc. (NYSE: TRV) is a leading provider of property casualty insurance for auto, home and business. A component of the Dow Jones Industrial Average, Travelers has approximately 30,000 employees and generated revenues of approximately $28 billion in 2016. For more information, visit www.travelers.com.

EN
09/08/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Travelers Companies Inc.

Travelers Companies Inc: 3 directors

Three Directors at Travelers Companies Inc gave away/sold 20,005 shares at between 0.000USD and 266.124USD. The significance rating of the trade was 79/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's...

Moody’s Ratings rates Travelers’ senior unsecured notes A2

New York , July 21, 2025 – Moody's Ratings (Moody's) has assigned an A2 rating to the $1.25 billion in senior unsecured notes to be issued by The Travelers Companies, Inc. ("Travelers", NYSE: TRV). The company intends to use the net proceeds for general corporate purposes, including to retire senior...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

S&P 500 and Nasdaq 100 Testing Initial Support In last week's 2/25/25 Compass, we discussed our expectation for near-term downside as the S&P 500 and Nasdaq 100 (QQQ) displayed several bearish short-term developments. We also said it likely means at least another 2-4 weeks of consolidation, and that if the S&P 500 remains below 6100 and 6150 resistances, do not be surprised if there is a test of the bottom of the range at either 5770-5850 or 5600-5670, where we would be buyers (though we need 5...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Continue Riding This Bull Market Higher Since early November 2023 we have laid out our bullish expectations for a year-end rally that we anticipated would continue into the early part of 2024. Here we are in the early part of 2024, and we see every reason to continue riding this bull market higher. Small- and Mid-Caps Resuming Uptrends. Looking at the big picture on the small-cap Russell 2000 (IWM) and the Vanguard Extended Market ETF (VXF, the entire U.S. market excluding the S&P 500), (1) th...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch